{'fraction_non_alphanumeric': 0.0162748643761302, 'fraction_numerical': 0.0, 'mean_word_length': 6.012658227848101, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Intrathecal baclofen: expanding treatment options for hypertonicity.

Adequate assessment and treatment of hypertonia has remained a challenging problem for physicians. Differentiating between the various characteristics of hypertonicity can lead to improved treatment options. While oral medications, focal chemo-denervation, chemical neurolysis and orthopedic surgeries continue to play a role in the management of pathologic tone, intrathecal delivery of baclofen has proven to be a safe and effective treatment in the clinical setting of hypertonia.